Have a personal or library account? Click to login
Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro Cover

Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro

Asian Biomedicine
Volume 16 (2022): Issue 2 (April 2022)
By: Chao-Yi Chen,  Jyh-Gang Leu,  Kuan-Yu Lin,  Chin-Yu Shih and  Yao-Jen Liang  
Open Access
|Apr 2022

Authors

Chao-Yi Chen

Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei City, Taiwan
Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan

Jyh-Gang Leu

Fu-Jen Catholic University School of Medicine, New Taipei City, Taiwan
Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

Kuan-Yu Lin

Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan

Chin-Yu Shih

Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei City, Taiwan

Yao-Jen Liang

071558@mail.fju.edu.tw

Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei City, Taiwan
Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan
DOI: https://doi.org/10.2478/abm-2022-0010 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 79 - 87
Published on: Apr 29, 2022
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
hypertrophy,
interleukin-18,
myocytes,
cardiac,
receptor,
serotonin,
5-HT2B,
signal transduction
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2022 Chao-Yi Chen, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih, Yao-Jen Liang, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 16 (2022): Issue 2 (April 2022)Next article